01 — At a Glance
The Restructuring Circus That Keeps Raising Backlog Records
- 52-Week High / Low₹1,418 / ₹830
- Q3 FY26 Revenue₹883.50 Cr
- Q3 FY26 PAT-₹8.89 Cr (Loss)
- 9M FY26 Revenue₹2,580 Cr
- EPS Q3-₹1.78
- Book Value₹262
- Price to Book3.36x
- Dividend Yield0.23%
- Order Backlog₹2,205 Cr
- Backlog Growth YoY+27%
The Auditor’s Bewildered Take: GMM Pfaudler reported Q3 FY26 revenue of ₹883.50 crore (+10.2% QoQ), but a PAT loss of ₹8.89 crore. This is after taking ₹56.32 crore in exceptional charges—₹44 crore for a German plant downsizing and ₹13 crore for an India labour code provision. Meanwhile, order backlog hit ₹2,205 crore (highest ever). Management is essentially saying: “Our future looks phenomenal. Our present? Well… that’s expensive.”
02 — Introduction
Welcome to Industrial Equipment Destiny: Boom Your Backlog, Torch Your Margins
GMM Pfaudler makes glass-lined equipment (GLE). These are essentially giant glass-coated vessels used in pharmaceutical plants, chemical factories, and other industries where “what touches the product must not react with it” is a non-negotiable requirement. They’ve got 50% market share in India, 40% in Europe, 50% in America. The company also makes mixing systems, filtration equipment, heavy engineering items, and once you buy from them, you need aftermarket services for decades.
The story of the past 12 months is this: Order intake is roaring. Backlog just hit record levels. The pharma and specialty chemicals industries are investing like they’re reinventing themselves. Nuclear orders are flowing. Defence contracts are showing up. And yet… profit margins are getting hammered.
Why? Because the company is undertaking a global restructuring that would make a consultant weep with joy. Closing the UK glass-lined factory entirely (completed Q4 FY25). Selling the Hyderabad property for ₹58.93 crore (just completed Feb 2026). Downsizing the Germany plant (taking ₹44 crore restructuring charge in Q3). Opening Poland as a low-cost manufacturing hub. It’s like watching a chess grandmaster sacrifice all their pieces to set up a checkmate in move 47.
The concall in Feb 2026 revealed the real strategy: The board believes glass-lined equipment is a mature business, and the way to win is to “cut cost.” Meanwhile, the mixing, systems, and heavy engineering verticals are where the real growth and juicier margins hide. But getting there requires short-term pain. Q3 FY26 is that pain materializing on the P&L.
Management’s Own Words (Feb 2026 Concall): “This quarter has been a stable quarter in terms of revenue and profitability… a good quarter in terms of order intake.” Translation: Revenue is flat. Profit turned negative. But backlog is incredible. Choose which metric to celebrate.
03 — Business Model: Industrial Vessels for the Obsessively Cautious
If It Touches Chemicals, It’s Probably From GMM Pfaudler (50% Chance).
The core business is simple: chemical and pharma industries need vessels that won’t corrode, react, or contaminate their products. GMM Pfaudler coats steel vessels with specialized glass linings, adds custom agitators, heating/cooling systems, and sells you the entire package. A single GLE order can take 3–9 months to execute. Heavy engineering orders? Up to 18 months. You design it, they manufacture, they deliver, they service it for 30+ years.
The portfolio is split into four buckets:
Technologies (60% of orders, FY24): The core glass-lined equipment and emerging non-GLE tech like Mixion (mixing), Mixel (French acquisition), MixPro (Canadian acquisition, ₹55 cr), Interseal (sealing), Mavag (filtration/drying). This is where the acquisition spree has been aggressive.
Services (28% of orders): Repair, refurbishment, technical support. These are margin-rich and sticky—a customer who bought a GLE vessel in 1995 still needs service in 2025. Recurring revenue. No inventory risk. The management explicitly called this “critical” in the concall, especially in overseas markets where services form ~40% of revenue.
Systems (12% of orders): Turnkey plants. Design a full chemical process, build it, commission it. Higher complexity, higher capex for GMM, but also higher margins if executed right. A EUR 33 million (₹330 crore) defence-linked systems order was disclosed in June 2025.
Heavy Engineering (20–25% of revenue): Vessels for oil & gas, metals, minerals, rare earths. Increasingly moving from carbon steel (was 90%, now 40%) to higher-value alloys (stainless, Hastelloy, Titanium). Export opportunities in Middle East, Saudi Arabia, Southeast Asia.
India GLE Share50%Market Leader
Europe GLE Share40%Top 3
America GLE Share50%Market Leader
China GLE Share20%Challenger
The Real Risk Nobody Is Pricing In: The company derives ~55–60% of GLE revenue from chemicals, ~20–25% from pharma. Both sectors are cyclical. Pharma capex is currently surging. But chemicals in Europe are facing “overcapacity and uncertainties in global trade” (management’s exact words). When these cycles flip, backlog means nothing—conversion matters.
💬 If your chemical plant ordered an expensive GLE vessel and then discovered a cost-cutting trick, would you still go through with it? That’s the conversion risk GMM faces. Drop your thoughts!
04 — Financials Overview
Q3 FY26: The Numbers That Make Auditors Flinch
Result type: Quarterly Results | Q3 FY26 EPS: -₹1.78 | Annualised EPS (Q3×4): -₹7.12 | 9M EPS: ₹9.51 (rolling average)
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 883.50 | 801.48 | 902.34 | +10.2% | -2.1% |
| Operating Profit | 104.96 | 95.87 | 121.56 | +9.5% | -13.7% |
| OPM % | 11.88% | 11.96% | 13.47% | -8 bps | -159 bps |
| PAT (before exceptionals) | 42.55 | 40.03 | 39.38 | +6.3% | +8.0% |
| Exceptional Charges | -56.32 | — | — | N/A | N/A |
| Reported PAT | -8.89 | 40.03 | 39.38 | -122.2% | -122.6% |
| EPS (₹) | -1.78 | 9.23 | 9.22 | -119.3% | -119.3% |
The Exceptional Story (It’s Exceptional For A Reason): ₹44 crore for German plant downsizing (staff reduction: 30+ headcount, 14 already gone in Q3, 16 over next year). ₹13 crore for India labour code provision. These are one-time. Underlying profit in Q3 before these charges: ₹42.55 crore (fairly stable YoY). Revenue growth is real (+10.2% YoY). But margins are compressing due to capacity underutilization in mature glass-lined business and cost reductions that haven’t fully phased in yet. Management expects savings to accelerate in FY27: ₹15–17 crore incremental benefit next year, then ₹25 crore full-year once fully phased in. Total potential savings: >₹40 crore/year. That’s material. But it takes time.
05 — Valuation Discussion: Fair Value Range
What’s This Restructuring Play Actually Worth?
Method 1: P/E Based (Normalised)
FY25 EPS (annualised, Mar 2025): ₹11.78 (includes some pain). Sector median P/E: 28.4x. GMM trades at 35.4x. Justified premium for market leadership: 1.15x–1.3x. Fair P/E band (normalised): 28x–35x.
Range: ₹330 – ₹412
Method 2: EV/EBITDA (Based on 9M FY26 Run-Rate)
9M FY26 EBITDA (approx): ₹358 Cr (running at ~12.5% margin). TTM EBITDA: ~₹411 Cr. Current EV: ₹4,540 Cr. EV/EBITDA: 10.5x (below peers at 10–15x range for quality equipment makers).
Fair EV/EBITDA range: 11x–14x (post-restructuring benefit). Assuming EBITDA reaches ₹500 Cr (16% margin target by management):
Range: ₹362 – ₹487
Method 3: Backlog-to-Revenue Conversion DCF
Order backlog: ₹2,205 Cr. Estimated conversion period: 18–24 months for 70–80% of backlog. Assuming 15% EBITDA margin (post-restructuring), management targets 16–18% mid-term.
→ PV of backlog conversion (50% in 12 months, 30% in 18 months): ~₹3,200 Cr
→ Terminal value (3% growth, 11% WACC): ~₹2,100 Cr
→ Less: Net debt (~₹750 Cr), less equity value: ~₹4,550 Cr
Range: ₹340 – ₹480
Fair Min: ₹330
CMP: ₹881 | Fair Max: ₹512
Upside: TBD
CMP ₹881 (vs Fair High ₹512)
Restructuring Upside TBD
⚠️ EduInvesting Fair Value Range: ₹330 – ₹512. CMP ₹881 is trading at the optimistic end of the fair range or slightly above, betting that restructuring benefits will be material and durably increase margins. This fair value range is for educational purposes only and is not investment advice. Please consult a SEBI-registered investment advisor before making financial decisions.
06 — What’s Cooking: News, Triggers, Drama
The Global Restructuring Saga Meets Record Backlog Energy
